Abstract:Background and Objectives: Physical exercise is an important therapeutic modality for treating and managing diabetes. High-intensity interval training (HIIT) is considered one of the best non-drug strategies for preventing and treating type 2 diabetes mellitus (T2DM) by improving mitochondrial biogenesis and function. This study aimed to determine the effects of 12 weeks of HIIT training on the expression of tumor suppressor protein-p53, mitochondrial cytochrome c oxidase (COX), and oxidative stress in patients with T2DM. Methods: A total of thirty male sedentary patients aged (45-60 years) were diagnosed with established T2DM for more than five years. Twenty healthy volunteers, age- and sex-matched, were included in this study. Both patients and control subjects participated in the HIIT program for 12 weeks. Glycemic control variables including p53 (U/mL), COX (ng/mL), total antioxidant capacity (TAC, nmole/µL), 8-hydroxy-2'-deoxyguanosine (8-OHdG, ng/mL), as well as genomic and mitochondrial DNA content were measured in both the serum and muscle tissues of control and patient groups following exercise training. Results: There were significant improvements in fasting glucose levels. HbA1c (%), HOMA-IR (mUmmol/L2), fasting insulin (µU/mL), and C-peptide (ng/mL) were reported in T2DM and healthy controls. A significant decrease was also observed in p53 protein levels. COX, 8-OhdG, and an increase in the level of TAC were reported in T2DM following 12 weeks of HIIT exercise. Before and after exercise, p53; COX, mt-DNA content, TAC, and 8-OhdG showed an association with diabetic control parameters such as fasting glucose (FG), glycated hemoglobin (HbA1C, %), C-peptide, fasting insulin (FI), and homeostatic model assessment for insulin resistance (HOMA-IR) in patients with T2DM. These findings support the positive impact of HIIT exercise in improving regulation of mitochondrial biogenesis and subsequent control of diabetes through anti-apoptotic and anti-oxidative pathways. Conclusions: A 12-week HIIT program significantly improves diabetes by reducing insulin resistance; regulating mitochondrial biogenesis; and decreasing oxidative stress capacity among patients and healthy controls. Also; p53 protein expression; COX; 8-OhdG; and TAC and mt-DNA content were shown to be associated with T2DM before and after exercise training.

The significance of tumor necrosis factor-α in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment

Short-term insulin intensive therapy for inflammation in newly-diagnosed type 2 diabetics

The analysis of relevant factors in intensive therapy to ameliorate insulin resistance in newly diagnosed type 2 diabetic patients

Short-term Intensive Therapy in Newly Diagnosed Type 2 Diabetes Partially Restores Both Insulin Sensitivity and Β-Cell Function in Subjects with Long-Term Remission.

A Study on the Relationship between TNF-α Level and Insulin Resistance in Patients with Type 2 Diabetes

Effect of short-term intensive insulin therapy on α-cell function in patients with newly diagnosed type 2 diabetes.

1032-P: Time-in-Range during Short-Term Intensive Insulin Therapy Is Associated with Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes

Effects of Short-Term Intensive Insulin Therapy on PancreaticβCell Functions and Serum Total Bile Acid Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

The Effect of Short-Term Intensive Insulin Therapy on Circulating T Cell Subpopulations in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.

Decreased circulating dipeptidyl peptidase-4 activity after short-term intensive insulin therapy predicts clinical outcomes in patients with newly diagnosed type 2 diabetes

The Changes and Their Significance of Serum Tumor Necrosis Factor-Α and Free Fatty Acids in Different Glycometabolic States

The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis

The effects of short-term insulin intensive treatment on islet B cell function and insulin sensitivity in newly-diagnosed Type 2 Diabetic Patients

Insulin Inhibits Tumor Necrosis Factor-Alpha Induction In Myocardial Ischemia/Reperfusion: Role Of Akt And Endothelial Nitric Oxide Synthase Phosphorylation

High-Intensity Interval Training Improves Glycemic Control, Cellular Apoptosis, and Oxidative Stress of Type 2 Diabetic Patients

[The Effect and Mechanism of Transient Continuous Subcutaneous Insulin Infusion Therapy on Beta Cell Function, Insulin Resistance and Vascular Endothelial Injury in Newly Diagnosed Type 2 Diabetes].

Effects of Intensive Insulin Therapy on Monocyte Chemotactic Protein-1 and Nuclear Factor-Κb of Newly-Diagnosed Type 2 Diabetic Patients

[Association of TNF-1031T/C and Clinical Efficacy of Insulin Therapy in Newly Diagnosed Type 2 Diabetics].

Effect of intensive insulin therapy on serum inflammatory factors in newly onset diabetic patients

Changes of Islet Β-Cell Function in Newly Diagnosed Type 2 Diabetes after Intensive Insulin Treatment

Protective Effects of Insulin on Islet B Cells in Newly Diagnosed Type 2 Diabetic Patients